http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102526705-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b073a9d9d1fa0ebeaa12dbc2f64eff46 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_30f5a810e0786d7c9c76e47ee3839235 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40262fcd7aaf09156993a458d263ee35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_046f142e674a4e40d4040f3402f54253 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89a9ce7fd8de9dfeedef72e68a7f31c0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d4c6306127ce1d99f7539d0974b1ded http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d300748fbd9500a245674a55a6b53c9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70010cd21754e1e0f4b3e1066753e947 |
| publicationDate | 2013-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102526705-B |
| titleOfInvention | Application of human ribosomal protein L23 label peptide in preparation of anti-cancer medicines |
| abstract | The invention discloses application of human ribosomal protein L23 label peptide to preparation of anti-cancer medicines. The amino acid sequence of the human ribosomal protein L23 label peptide is defined by SEQ ID NO:1. The human ribosomal protein L23 label peptide has time and dose dependence on growth inhibition rate of human breast cancer Bcap-37. The human ribosomal protein L23 label peptide at the concentrations of 0.2, 0.5 and 0.8 ug/ml has a good effect on growth inhibition of the human breast cancer Bcap-37, wherein the growth inhibition ratio of the human ribosomal protein L23 label peptide at the concentration of 0.5 ug/ml on the human breast cancer Bcap-37 is highest and reaches 72.29 percent. |
| priorityDate | 2012-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 371.